Franklin Covey Company FC
17.31
0.04
0.23%
as of 25 Sep
- Market cap
- $195.1M
- P/E
- 96.2×
Follow FC
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
78.36 | 0.00 | 0.00 | 134.22 |
P/S ratio |
0.95 | 0.74 | 0.56 | 1.04 | |
P/FCF ratio |
19.24 | 0.00 | 10.06 | 25.32 | |
P/Operating CF |
25.48 | 1,968.55 | 9.00 | 241.81 | |
P/B ratio |
3.78 | 3.57 | 3.85 | 6.34 | |
Price to Tangible BV |
222.14 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.84 | 0.68 | 0.52 | 1.00 | |
EV/EBITDA |
11.66 | 12.65 | 10.02 | 13.05 | |
EV/Operating CF |
7.73 | 11.92 | 4.15 | 9.58 | |
EV/FCF |
17.02 | (80.72) | 9.29 | 24.44 | |
Quick Ratio |
0.64 | 0.52 | 0.42 | 0.44 | |
Current Ratio |
0.82 | 0.73 | 0.63 | 0.66 | |
Net Debt/EBITDA |
(2.77) | 40.85 | (10.24) | (1.55) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.06 | 1.14 | 1.23 | 1.26 | |
Operating CF/Net income |
2.27 | (0.03) | (8.20) | 0.36 | |
Capex/Depreciation |
(2.15) | (1.16) | (0.93) | (0.61) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
61.98% | 72.01% | 72.92% | 63.80% | |
Intangible Assets out of Total Assets |
0.27 | 0.29 | 0.31 | 0.32 | |
Share Based Compensation of Revenue |
0.11% | 2.23% | 4.47% | 2.21% | |
Graham Net Nets |
(0.18) | (0.30) | (0.50) | (0.23) | |
Graham Number |
5.40 | 0.00 | 0.00 | 3.93 | |
Earnings Yield |
1.28% | (0.70%) | (1.56%) | 0.75% | |
Free Cash Flow Yield |
5.20% | (1.14%) | 9.94% | 3.95% | |
Revenue per Share |
5.51 | 5.25 | 5.22 | 6.02 | |
Operating CF per Share |
0.77 | 0.01 | 1.42 | 0.10 | |
Capex per Share |
(0.59) | (0.31) | (0.27) | (0.19) | |
Free Cash Flow per Share |
0.18 | (0.30) | 1.15 | (0.09) | |
Cash per Share |
2.45 | 1.44 | 1.20 | 1.06 | |
Shareholders Equity per Share |
5.18 | 4.42 | 3.33 | 3.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.18 | 4.42 | 3.33 | 3.81 | |
Free Cash Flow |
2.27 | (3.65) | 13.16 | (1.03) | |
Working Capital |
(27.81) | (39.71) | (56.81) | (48.32) | |
Capital Expenditures |
(7.67) | (3.75) | (3.10) | (2.15) | |
Net Current Asset Value |
(46.52) | (58.23) | (73.01) | (63.27) | |
EV/EBIT |
39.28 | 307.80 | 3,973.88 | 40.82 | |
Capex to Sales |
0.11 | 0.06 | 0.05 | 0.03 | |
Net Profit Margin |
6.14% | (5.14%) | (3.32%) | 4.55% | |
Price to Operating Income |
44.40 | 333.77 | 4,303.41 | 42.29 | |
| Other line items | |||||
Average Receivables |
77.21 | 60.28 | 51.74 | 50.06 | |
Average Payables |
8.32 | 5.75 | 6.70 | 6.33 | |
Average Inventory |
4.58 | 4.57 | 4.72 | 4.93 | |
Average Assets |
252.23 | 230.58 | 213.91 | 208.15 | |
Average Common Equity |
75.02 | 67.33 | 55.29 | 54.26 |
Columns are period end dates